P14.05.B CAR T-CELL THERAPY DOES NOT LEAD TO MEDIUM-TERM NEUROCOGNITIVE DETERIORATION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS. A LOC NETWORK STUDY
Notice bibliographique
Résumé
Abstract BACKGROUND Several recent studies have shown promising efficacy of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in central nervous system (CNS) lymphomas. Data regarding neurotoxicity were reassuring, with rates of severe acute neurotoxicity similar to those described in systemic lymphomas. However, recently published data from our group outlined the risk of prolonged neurologic deterioration in patients who experienced severe neurotoxicity, which is unusual in systemic lymphomas. The aim of this study was to evaluate mid-term neurocognitive outcomes in CNS lymphomas treated with CAR T-cells. MATERIAL AND METHODS Patients were retrospectively selected from the French LOC network database according to the following criteria: 1) CNS lymphoma treated with CAR T-cells at Pitié-Salpêtrière hospital; 2) Isolated CNS relapse at the time of leukapheresis; 3) Availability of neuropsychological follow-up. Neuropsychological assessment was performed as part of the usual care, before CAR T-cell infusion and, in the absence of tumoral progression, 6 weeks (W6), 6 months (M6) and 12 months (M12) after CAR T-cell therapy. RESULTS Of 38 CNS lymphomas who received CAR T-cells between May 2021 and March 2024, 30 patients (median age: 61 years (range: 30-82), 17 women, 14 primary, 16 secondary CNS lymphomas) benefited from repeated neuropsychological assessments. At the time of CAR T-cell infusion, 7 had stable or progressive disease, median Karnofsky Performance Status (KPS) was 75 and median Montreal Cognitive Assessment (MoCA) score was 23.5 (range: 11-29). Eleven patients received tisagenlecleucel, 17 axicabtagene ciloleucel and 2 brexucabtagene autoleucel. Nineteen patients experienced acute neurotoxicity, including 6 cases of grade 3-4 neurotoxicity. Twenty-two patients were assessed up to M12 (all other patients progressed). Clustering of these longitudinal data using a k-means approach revealed at W6 a subgroup of patients (n=22) with stable or improved cognitive functioning and a subgroup (n=8) with worsened cognitive functioning. Membership to these clusters was strongly associated with the occurrence and severity of an acute neurotoxicity (p=0.01). At M12, there was a statistically significant improvement of MoCA score (median 26 vs 23.5, p<0.001) compared to baseline. Scores addressing memory, executive functions, visuo-spatial functions and anxiety/depression also improved, although not significantly. Such improvements were already seen at M6, and applied both to the whole population and to the subgroup who experienced grade 3-4 neurotoxicity. CONCLUSION Mid-term neurocognition follow-up of patients with CNS lymphoma treated by CAR T-cells seems reassuring, with no significant cognitive worsening, even in patients who experienced severe acute neurotoxicity. These results should be confirmed with longer follow-up.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,001 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».